Association between plasminogen activator inhibitor-1 in young adulthood and nonalcoholic fatty liver disease in midlife: CARDIA (Q89851343)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32090434 AND SRC:MED&resulttype=core&format=json

9 April 2020

title

Association between plasminogen activator inhibitor-1 in young adulthood and nonalcoholic fatty liver disease in midlife: CARDIA (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32090434 AND SRC:MED&resulttype=core&format=json

9 April 2020

1 reference

metabolic dysfunction–associated steatotic liver disease

1 reference

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32090434 AND SRC:MED&resulttype=core&format=json

9 April 2020

Veeral H Ajmera

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32090434 AND SRC:MED&resulttype=core&format=json

9 April 2020

Sadiya S Khan

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32090434 AND SRC:MED&resulttype=core&format=json

9 April 2020

7

Donald M Lloyd-Jones

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32090434 AND SRC:MED&resulttype=core&format=json

9 April 2020

author name string

Patrick T Campbell

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32090434 AND SRC:MED&resulttype=core&format=json

9 April 2020

Laura A Colangelo

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32090434 AND SRC:MED&resulttype=core&format=json

9 April 2020

Cora E Lewis

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32090434 AND SRC:MED&resulttype=core&format=json

9 April 2020

Anne Henkel

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32090434 AND SRC:MED&resulttype=core&format=json

9 April 2020

Douglas E Vaughan

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32090434 AND SRC:MED&resulttype=core&format=json

9 April 2020

publication date

23 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32090434 AND SRC:MED&resulttype=core&format=json

9 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32090434 AND SRC:MED&resulttype=core&format=json

CARDIA: study design, recruitment, and some characteristics of the examined subjects

9 April 2020

cites work

1 reference

12 December 2020

Enzymatic methods for quantification of lipoprotein lipids

1 reference

12 December 2020

Seven-year trends in plasma low-density-lipoprotein-cholesterol in young adults: the CARDIA Study

1 reference

12 December 2020

Adipose tissue secretion of plasminogen activator inhibitor-1 in non-obese and obese individuals

1 reference

12 December 2020

Impact of adipose tissue on plasma plasminogen activator inhibitor-1 in dieting obese women

1 reference

12 December 2020

Role of cytokines in the regulation of plasminogen activator inhibitor-1 expression and secretion in newly differentiated subcutaneous human adipocytes

1 reference

12 December 2020

Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: the insulin resistance atherosclerosis study

1 reference

12 December 2020

Plasma PAI-1 levels are more strongly related to liver steatosis than to adipose tissue accumulation

1 reference

12 December 2020

Relationship of metabolic syndrome and fibrinolytic dysfunction to cardiovascular disease

1 reference

12 December 2020

Cardiovascular disease risk factors predict the development of type 2 diabetes: the insulin resistance atherosclerosis study

1 reference

12 December 2020

Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity

1 reference

12 December 2020

Pleiotropic functions of plasminogen activator inhibitor-1.

1 reference

12 December 2020

Macrovesicular hepatic steatosis in living liver donors: use of CT for quantitative and qualitative assessment

1 reference

12 December 2020

PAI-1 and the metabolic syndrome: links, causes, and consequences

1 reference

12 December 2020

Comparison of CT methods for determining the fat content of the liver

1 reference

12 December 2020

Plasma PAI-1 levels are increased in patients with nonalcoholic steatohepatitis

1 reference

12 December 2020

Non-alcoholic fatty liver disease is strongly associated with carotid atherosclerosis: a systematic review

1 reference

12 December 2020

Circulating levels and hepatic expression of molecular mediators of atherosclerosis in nonalcoholic fatty liver disease

1 reference

12 December 2020

The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis

1 reference

12 December 2020

Relationship between Kidney Function and Liver Histology in Subjects with Nonalcoholic Steatohepatitis

1 reference

12 December 2020

Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity

1 reference

12 December 2020

Fructose-induced steatosis in mice: role of plasminogen activator inhibitor-1, microsomal triglyceride transfer protein and NKT cells.

1 reference

12 December 2020

Changes in the Prevalence of the Most Common Causes of Chronic Liver Diseases in the United States From 1988 to 2008

1 reference

12 December 2020

Computed tomography scans in the evaluation of fatty liver disease in a population based study: the multi-ethnic study of atherosclerosis

1 reference

12 December 2020

The diagnosis and management of non-alcoholic fatty liver disease: Practice guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association

1 reference

12 December 2020

Nonalcoholic fatty liver disease in lean individuals in the United States

1 reference

12 December 2020

Prothrombotic factors in histologically proven nonalcoholic fatty liver disease and nonalcoholic steatohepatitis

1 reference

12 December 2020

Associations between nonalcoholic fatty liver disease and subclinical atherosclerosis in middle-aged adults: the Coronary Artery Risk Development in Young Adults Study

1 reference

12 December 2020

Plasminogen activator inhibitor-1 is independently associated with non-alcoholic fatty liver disease whereas leptin and adiponectin vary between genders

1 reference

12 December 2020

Ideal cardiovascular health: associations with biomarkers and subclinical disease and impact on incidence of cardiovascular disease in the Framingham Offspring Study

1 reference

12 December 2020

Nonalcoholic fatty liver disease: a systematic review

1 reference

12 December 2020

Nonalcoholic fatty liver disease is associated with an almost twofold increased risk of incident type 2 diabetes and metabolic syndrome. Evidence from a systematic review and meta-analysis.

1 reference

12 December 2020

Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes.

1 reference

12 December 2020

Novel plasma biomarkers associated with liver disease severity in adults with nonalcoholic fatty liver disease

1 reference

12 December 2020

Association between plasminogen activator inhibitor-1 and severity of liver injury and cardiovascular risk in children with non-alcoholic fatty liver disease

1 reference

12 December 2020

American Gastroenterological Association Institute Technical Review on the Role of Elastography in Chronic Liver Diseases

1 reference

12 December 2020

Ultrasonographic fatty liver indicator detects mild steatosis and correlates with metabolic/histological parameters in various liver diseases

1 reference

12 December 2020

Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention

1 reference

12 December 2020

Non-invasive assessment of non-alcoholic fatty liver disease: Clinical prediction rules and blood-based biomarkers

1 reference

12 December 2020

TM5441, a plasminogen activator inhibitor-1 inhibitor, protects against high fat diet-induced non-alcoholic fatty liver disease

1 reference

12 December 2020

Nonalcoholic Fatty Liver Disease and Risk of Incident Type 2 Diabetes: A Meta-analysis.

1 reference

12 December 2020

Twenty-five-year trajectories of insulin resistance and pancreatic β-cell response and diabetes risk in nonalcoholic fatty liver disease.

1 reference

12 December 2020

Noninvasive biomarkers in NAFLD and NASH - current progress and future promise

1 reference

12 December 2020

Current guidelines for the management of non-alcoholic fatty liver disease: A systematic review with comparative analysis

1 reference

12 December 2020

Inhibition of Plasminogen Activator Inhibitor 1 Attenuates Hepatic Steatosis but Does Not Prevent Progressive Nonalcoholic Steatohepatitis in Mice.

1 reference

12 December 2020

Ultrasound Fatty Liver Indicator: A Simple Tool for Differentiating Steatosis From Nonalcoholic Steatohepatitis: Validity in the Average Obese Population

1 reference

12 December 2020